Clinical overview of cutaneous features in hypereosinophilic syndrome.

Current Allergy and Asthma Reports
Sabine Gisela PlötzJohannes Ring

Abstract

The hypereosinophilic syndromes (HES) are a heterogeneous group of disorders defined as persistent and marked blood eosinophilia of unknown origin with systemic organ involvement. HES is a potentially severe multisystem disease associated with considerable morbidity. Skin involvement and cutaneous findings frequently can be seen in those patients. Skin symptoms consist of angioedema; unusual urticarial lesions; and eczematous, therapy-resistant, pruriginous papules and nodules. They may be the only obvious clinical symptoms. Cutaneous features can give an important hint to the diagnosis of this rare and often severe illness. Based on advances in molecular and genetic diagnostic techniques and on increasing experience with characteristic clinical features and prognostic markers, therapy has changed radically. Current therapies include corticosteroids, hydroxyurea, interferon-α, the tyrosine kinase inhibitor imatinib mesylate, and (in progress) the monoclonal anti-interleukin-5 antibodies. This article provides an overview of current concepts of disease classification, different skin findings, and therapy for HES.

References

May 1, 1979·Archives of Dermatology·G T Spigel, R K Winkelmann
Apr 1, 1978·Archives of Dermatology·J A KazmierowskiS M Wolff
Aug 1, 1978·Annals of Internal Medicine·J E ParrilloS M Wolff
Nov 1, 1992·Internal Medicine·M TakekawaA Yachi
Oct 1, 1992·Immunology Today·C J SpryG J Gleich
Dec 1, 1992·Journal of the American Academy of Dermatology·S I Chun, H G Ji
Jan 1, 1992·Advances in Pharmacology·C J Sanderson
Nov 1, 1990·Annals of Internal Medicine·R M Zielinski, W D Lawrence
Mar 1, 1988·Neurology·S MonacoN Rizzuto
Jan 1, 1985·Annals of Internal Medicine·P M MooreA S Fauci
Nov 1, 1988·The Annals of Thoracic Surgery·W G HendrenM D Smith
Feb 1, 1988·Digestive Diseases and Sciences·B CroffyM Kaplan
Nov 1, 1987·Pediatric Dermatology·N Kamani, P J Lipsitz
Apr 1, 1985·Archives of Dermatology·H M van den HoogenbandM W van Diggelen
Apr 1, 1985·Archives of Internal Medicine·L Elouaer-BlancD Dhumeaux
Jun 21, 1984·The New England Journal of Medicine·G J GleichP F Kohler
Feb 19, 1982·JAMA : the Journal of the American Medical Association·K M LeifermanG J Gleich
May 1, 1982·Clinical and Experimental Dermatology·H M van den Hoogenband
Dec 1, 1982·Ophthalmology·G ChaineC J Spry
Nov 1, 1994·Annals of Internal Medicine·J H Butterfield, G J Gleich
Feb 1, 1994·Current Opinion in Immunology·P F Weller
Jul 1, 1993·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J H ButterfieldG J Gleich
Mar 1, 1996·The British Journal of Dermatology·W K JacykK M Leiferman
Jun 1, 1997·The British Journal of Dermatology·H YagiM Takigawa
Oct 6, 1997·Journal of the American Academy of Dermatology·R M TrüebG Burg
Feb 21, 1998·The British Journal of Dermatology·T BogenriederM Landthaler
Mar 28, 1998·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A EberleinP Altmeyer
Dec 16, 1998·The Journal of Allergy and Clinical Immunology·S G PlötzH U Simon
Jan 5, 1999·Dermatology : International Journal for Clinical and Investigative Dermatology·R ChikamaH Tagami
Oct 8, 1999·The New England Journal of Medicine·H U SimonK Blaser
May 2, 2000·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S G PlötzJ Ring
Jul 11, 2000·British Journal of Haematology·F RoufosseE Cogan
Aug 23, 2000·Acta Dermato-venereologica·S G PlötzJ Ring
Apr 18, 2001·International Archives of Allergy and Immunology·H U SimonK Blaser
Jun 6, 2002·Lancet·Gerald J GleichJoseph H Butterfield
Sep 5, 2002·The Journal of Allergy and Clinical Immunology·Aurore de LavareilleMichel Goldman

❮ Previous
Next ❯

Citations

Jun 26, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·A Erika MorrisGailen D Marshall
Dec 30, 2014·Annales de dermatologie et de vénéréologie·M-S Doutre
Jun 21, 2018·Anais Brasileiros De Dermatologia·Maira Renata MerlottoHélio Amante Miot
May 13, 2020·American Journal of Clinical Dermatology·Angelo Valerio Marzano, Giovanni Genovese
Jan 1, 2018·Anais Brasileiros De Dermatologia·Maira Renata MerlottoHélio Amante Miot
Feb 25, 2021·Scandinavian Journal of Immunology·Harald RenzJohannes Ring
Jun 10, 2021·BMJ Case Reports·Mehdi KhallaayouneKarima Senouci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Immunology and Allergy Clinics of North America
Javed Sheikh, Peter F Weller
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
J L ArmstrongC F Meyer
Current Opinion in Hematology
Javed Sheikh, Peter F Weller
© 2022 Meta ULC. All rights reserved